Literature DB >> 31537313

A Microwell Cell Capture Device Reveals Variable Response to Dobutamine in Isolated Cardiomyocytes.

J Alexander Clark1, Jonathan D Weiss1, Stuart G Campbell2.   

Abstract

Isolated ventricular cardiomyocytes exhibit substantial cell-to-cell variability, even when obtained from the same small volume of myocardium. In this study, we investigated the possibility that cardiomyocyte responses to β-adrenergic stimulus are also highly heterogeneous. To achieve the throughput and measurement duration desired for these experiments, we designed and validated a novel microwell system that immobilizes and uniformly orients isolated adult cardiomyocytes. In this configuration, detailed drug responses of dozens of cells can be followed for intervals exceeding 1 h. At the conclusion of an experiment, specific cells can also be harvested via a precision aspirator for single-cell gene expression profiling. Using this system, we followed changes in Ca2+ signaling and contractility of individual cells under sustained application of either dobutamine or omecamtiv mecarbil. Both compounds increased average cardiomyocyte contractility over the course of an hour, but responses of individual cells to dobutamine were significantly more variable. Surprisingly, some dobutamine-treated cardiomyocytes augmented Ca2+ release without increasing contractility. Other cells responded with increased contractility despite unchanged Ca2+ release. Single-cell gene expression analysis revealed significant co-expression of β-adrenergic pathway genes PKA regulatory subunit type I, PKA regulatory subunit type II, and Ca2+/calmodulin-dependent protein kinase II across cardiomyocytes. Other data supported a connection between the effects of dobutamine on relaxation rate and the expression of protein phosphatase 2. These findings suggest that variable drug responses among cells are not merely experimental artifacts. By enabling direct comparison of the functional behavior of an individual cell and the genes it expresses, this new system constitutes a unique tool for interrogating cardiomyocyte drug responses and discovering the genes that modulate them.
Copyright © 2019 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31537313      PMCID: PMC6818147          DOI: 10.1016/j.bpj.2019.08.024

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  21 in total

1.  β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.

Authors:  Jorge A Negroni; Stefano Morotti; Elena C Lascano; Aldrin V Gomes; Eleonora Grandi; José L Puglisi; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2015-02-25       Impact factor: 5.000

Review 2.  Cardiac beta-adrenergic signaling: from subcellular microdomains to heart failure.

Authors:  Jeffrey J Saucerman; Andrew D McCulloch
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

Review 3.  Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.

Authors:  Alexandre J S Ribeiro; Olivier Schwab; Mohammad A Mandegar; Yen-Sin Ang; Bruce R Conklin; Deepak Srivastava; Beth L Pruitt
Journal:  Circ Res       Date:  2017-04-11       Impact factor: 17.367

4.  Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.

Authors:  Balázs Horváth; Norbert Szentandrássy; Roland Veress; János Almássy; János Magyar; Tamás Bányász; Attila Tóth; Zoltán Papp; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-22       Impact factor: 3.000

5.  Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation.

Authors:  Carl W Tong; Xin Wu; Yang Liu; Paola C Rosas; Sakthivel Sadayappan; Andy Hudmon; Mariappan Muthuchamy; Patricia A Powers; Héctor H Valdivia; Richard L Moss
Journal:  Circ Heart Fail       Date:  2015-03-04       Impact factor: 8.790

6.  Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation.

Authors:  R Zhang; J Zhao; A Mandveno; J D Potter
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

7.  Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function.

Authors:  Laurin M Hanft; Timothy D Cornell; Colin A McDonald; Michael J Rovetto; Craig A Emter; Kerry S McDonald
Journal:  Arch Biochem Biophys       Date:  2016-02-15       Impact factor: 4.013

8.  cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits.

Authors:  T Gao; A Yatani; M L Dell'Acqua; H Sako; S A Green; N Dascal; J D Scott; M M Hosey
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

9.  Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.

Authors:  Lili Wang; Kyungsoo Kim; Shan Parikh; Adrian Gabriel Cadar; Kevin R Bersell; Huan He; Jose R Pinto; Dmytro O Kryshtal; Bjorn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2017-12-05       Impact factor: 5.000

10.  Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C.

Authors:  Gerrida M Uys; Amsha Ramburan; Benjamin Loos; Craig J Kinnear; Lundi J Korkie; Jomien Mouton; Johann Riedemann; Johanna C Moolman-Smook
Journal:  BMC Cell Biol       Date:  2011-05-10       Impact factor: 4.241

View more
  1 in total

1.  Contractile State Dependent Sarcomere Length Variability in Isolated Guinea-Pig Cardiomyocytes.

Authors:  Oleg Lookin; Anastasia Khokhlova; Tatiana Myachina; Xenia Butova; Olivier Cazorla; Pieter de Tombe
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.